Methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to treat proliferative disease

• 收藏
• 分享

专利权人:

Ambit Biosciences Corp.

发明人:

James, Joyce K.,Savall, Traci L.,Eichelberger, Shawn R.

申请号：

AU2008325141

公开号：

AU2008325141B2

申请日:

2008.11.07

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

Provided herein are methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea,or a pharmaceutically acceptable salt or solvate thereof, to human patients.Specifically, dosing, dosing schedules or dosing regimens are provided herein.Further, pharmaceutical formulations are provided. Methods of treating proliferativediseases or FLT-3 mediated diseases in humans are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/